3.50
price up icon7.36%   0.24
after-market After Hours: 3.66 0.16 +4.57%
loading
Briacell Therapeutics Corp stock is traded at $3.50, with a volume of 357.04K. It is up +7.36% in the last 24 hours and up +13.64% over the past month. BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.
See More
Previous Close:
$3.26
Open:
$3.36
24h Volume:
357.04K
Relative Volume:
1.81
Market Cap:
$30.45M
Revenue:
-
Net Income/Loss:
$-30.98M
P/E Ratio:
-0.2866
EPS:
-12.2116
Net Cash Flow:
$-31.84M
1W Performance:
+12.90%
1M Performance:
+13.64%
6M Performance:
-51.19%
1Y Performance:
+20.27%
1-Day Range:
Value
$3.35
$3.70
1-Week Range:
Value
$3.07
$3.70
52-Week Range:
Value
$0.61
$14.68

Briacell Therapeutics Corp Stock (BCTX) Company Profile

Name
Name
Briacell Therapeutics Corp
Name
Phone
(604) 921-1810
Name
Address
3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR, WEST VANCOUVER
Name
Employee
4
Name
Twitter
Name
Next Earnings Date
2026-06-15
Name
Latest SEC Filings
Name
BCTX's Discussions on Twitter

Compare BCTX vs VRTX, REGN, ARGX, ALNY, RVMD

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
BCTX icon
BCTX
Briacell Therapeutics Corp
3.50 28.19M 0 -30.98M -31.84M -12.21
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
529.59 126.07B 12.34B 4.34B 3.71B 16.87
REGN icon
REGN
Regeneron Pharmaceuticals Inc
649.81 65.37B 14.92B 4.42B 3.79B 41.04
ARGX icon
ARGX
Argen X Se Adr
916.80 57.70B 4.16B 1.29B 734.26M 19.58
ALNY icon
ALNY
Alnylam Pharmaceuticals Inc
313.04 40.19B 4.29B 577.22M 641.34M 4.2086
RVMD icon
RVMD
Revolution Medicines Inc
189.99 39.82B 742.00K -1.37B -1.07B -7.0731

Briacell Therapeutics Corp Stock (BCTX) Upgrades & Downgrades

Date Action Analyst Rating Change
Feb-14-22 Initiated H.C. Wainwright Buy

Briacell Therapeutics Corp Stock (BCTX) Latest News

pulisher
Jun 30, 2026

Why did BCTX stock surge 50% today? - MSN

Jun 30, 2026
pulisher
Jun 29, 2026

Number of shareholders of BriaCell Therapeutics Corp. – NASDAQ:BCTXZ - TradingView

Jun 29, 2026
pulisher
Jun 29, 2026

Price to book forward of BriaCell Therapeutics Corp. – NASDAQ:BCTXZ - TradingView

Jun 29, 2026
pulisher
Jun 29, 2026

Price to sales forward of BriaCell Therapeutics Corp. – NASDAQ:BCTXZ - TradingView

Jun 29, 2026
pulisher
Jun 28, 2026

Enterprise value to EBIT forward of BriaCell Therapeutics Corp. – BOATS:BCTXZ - TradingView

Jun 28, 2026
pulisher
Jun 27, 2026

Price to earnings forward of BriaCell Therapeutics Corp – TSX:BCT - TradingView

Jun 27, 2026
pulisher
Jun 27, 2026

Price to sales forward of BriaCell Therapeutics Corp. – BOATS:BCTXZ - TradingView

Jun 27, 2026
pulisher
Jun 27, 2026

Price to earnings forward of BriaCell Therapeutics Corp. – BOATS:BCTXZ - TradingView

Jun 27, 2026
pulisher
Jun 27, 2026

Enterprise value to revenue forward of BriaCell Therapeutics Corp. – NASDAQ:BCTX - TradingView

Jun 27, 2026
pulisher
Jun 27, 2026

Price to sales forward of BriaCell Therapeutics Corp. – NASDAQ:BCTX - TradingView

Jun 27, 2026
pulisher
Jun 27, 2026

Enterprise value to EBITDA forward of BriaCell Therapeutics Corp. – NASDAQ:BCTX - TradingView

Jun 27, 2026
pulisher
Jun 26, 2026

BriaCell subsidiary BriaPro reports $1.32M assets, $299,950 cash after sCD80 license acquisition - TradingView

Jun 26, 2026
pulisher
Jun 26, 2026

BriaCell (NASDAQ: BCTX) unit BriaPro posts loss and acquires sCD80 license - Stock Titan

Jun 26, 2026
pulisher
Jun 26, 2026

symbol__ Stock Quote Price and Forecast - CNN

Jun 26, 2026
pulisher
Jun 26, 2026

What Does BriaCell's Latest Offering Mean for Shareholders - Kavout | AI

Jun 26, 2026
pulisher
Jun 26, 2026

BriaCell Therapeutics Corp Actuals & Estimates (TSX:BCT) - TradingView

Jun 26, 2026
pulisher
Jun 25, 2026

BriaCell Partners with Uneedle for Scalable Microneedle Administration of Bria-IMT - marketscreener.com

Jun 25, 2026
pulisher
Jun 25, 2026

BriaCell (BCTX) Partners with Uneedle for Microneedle Technology Development - GuruFocus

Jun 25, 2026
pulisher
Jun 25, 2026

BriaCell plans microneedle delivery scale-up for breast cancer drug - Stock Titan

Jun 25, 2026
pulisher
Jun 24, 2026

Beyond the Syringe: How Microneedles Could Redefine Cancer Care - BriefGlance

Jun 24, 2026
pulisher
Jun 23, 2026

Briacell Therapeutics Corp (BCTX) Institutional Confidence - TradingKey

Jun 23, 2026
pulisher
Jun 18, 2026

Briacell Therapeutics Corp (BCTX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Jun 18, 2026
pulisher
Jun 18, 2026

Briacell Therapeutics Corp (BCTX) Valuation: PE, PB & Fair Value Analysis - TradingKey

Jun 18, 2026
pulisher
Jun 18, 2026

Briacell Therapeutics Corp (BCTX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Jun 18, 2026
pulisher
Jun 18, 2026

Briacell Therapeutics Corp (BCTXW) Institutional Confidence - TradingKey

Jun 18, 2026
pulisher
Jun 17, 2026

Briacell Therapeutics Corp (BCTX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

Briacell Therapeutics Corp (BCTXW) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

Briacell Therapeutics Corp (BCTXW) Valuation: PE, PB & Fair Value Analysis - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

Briacell Therapeutics Corp (BCTXW) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

Briacell Therapeutics Corp (BCTXW) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

Briacell Therapeutics Corp (BCTXW) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

Briacell Therapeutics Corp (BCTX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

Briacell Therapeutics Corp (BCTX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

Briacell Therapeutics Corp (BCTX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

Briacell Therapeutics Corp (BCTX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

Briacell Therapeutics Corp (BCTXW) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

Briacell Therapeutics Corp (BCTXW) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

Briacell Therapeutics Corp - TradingKey

Jun 17, 2026
pulisher
Jun 12, 2026

Why Briacell Therapeutics Corp stock is rising today - Wealth Awesome

Jun 12, 2026
pulisher
Jun 11, 2026

Why Briacell Therapeutics Corp stock is plummeting today - Wealth Awesome

Jun 11, 2026
pulisher
Jun 11, 2026

BCTXZ SEC FilingsBriacell Therapeutics Corp 10-K, 10-Q, 8-K Forms - Stock Titan

Jun 11, 2026
pulisher
Jun 11, 2026

BCTX Q1 2026 Earnings: Narrower-Than-Expected Loss Fails to Lift Shares Amid Revenue AbsenceROE Trend Analysis - newsline.com

Jun 11, 2026
pulisher
Jun 09, 2026

BriaCell (NASDAQ: BCTX) ramps cancer trials but flags going concern risk - Stock Titan

Jun 09, 2026
pulisher
Jun 09, 2026

BriaCell Therapeutics Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2026 - marketscreener.com

Jun 09, 2026
pulisher
Jun 04, 2026

BriaCell receives FDA clearance for breast cancer therapy trial - Investing.com

Jun 04, 2026
pulisher
Jun 04, 2026

BriaCell Therapeutics Completes Equity Offering to Fund Operations - The Globe and Mail

Jun 04, 2026
pulisher
Jun 03, 2026

Immunotherapy Innovations: Increasing Survival in Metastatic Breast Cancer - Investing News Network

Jun 03, 2026
pulisher
Jun 03, 2026

BriaCell (NASDAQ: BCTX) completes $4.71M best efforts common share sale - Stock Titan

Jun 03, 2026
pulisher
Jun 03, 2026

BriaCell Therapeutics Prices $4.71 Million Share Offering at $3.25; ThinkEquity as Placement Agent - TradingView

Jun 03, 2026
pulisher
Jun 02, 2026

Beyond the Lab: Top-Tier Clinical Validation in Biotech Investing - Investing News Network

Jun 02, 2026
pulisher
Jun 02, 2026

BriaCell Therapeutics Rises After Hours as It Closes a $4.7-Million Share Offering - Moomoo

Jun 02, 2026

Briacell Therapeutics Corp Stock (BCTX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$111.54
price down icon 0.05%
$56.92
price down icon 1.47%
$35.39
price up icon 0.74%
ONC ONC
$309.46
price up icon 3.97%
$81.80
price up icon 2.56%
$189.99
price up icon 0.40%
Cap:     |  Volume (24h):